Mutational inactivation of PTEN frequently occurs in human cancers; however, early molecular tumor-promoting mechanisms in PTEN expressing (PTEN+) cancer cells, such as those in early developing melanoma, remain unclear. The gene discussed is PTEN; the disease is neoplasm.